Viewing nowRivatin Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

MFDS item code 201309488 · Approved 2013.09.30 · Insurance code 670103460
Reduction of the risk of myocardial infarction and stroke, and improvement of hyperlipidemia
This medication helps reduce the risk of cardiovascular diseases. It reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease or in patients with type 2 diabetes. Additionally, in patients who already have coronary heart disease, it lowers the risks associated with myocardial infarction, stroke, vascular surgeries, congestive heart failure, and angina. It also reduces total cholesterol and LDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL-cholesterol, thereby improving blood lipid levels. It serves as an effective adjunctive therapy for patients with dyslipidemia not controlled by diet. Moreover, it is used in children and adolescents aged 10 to 17 years with familial hypercholesterolemia to help lower cholesterol levels.
For hyperlipidemia, the recommended starting dose is 10 mg once daily. For patients requiring greater LDL-cholesterol reduction, it may start at 20 mg or 40 mg once daily. This medication is administered within a range of 10 to 80 mg once daily. The initial and maintenance doses are individualized based on patient characteristics, with lipid levels analyzed every 2 to 4 weeks to adjust the dosage. The goal of treatment is to lower LDL-cholesterol levels, so it is recommended to monitor LDL-cholesterol levels at the start of treatment and during response evaluations. However, if LDL-cholesterol levels cannot be monitored, total cholesterol levels may be used to monitor treatment response. In patients with homozygous familial hypercholesterolemia, the treatment dose is 10 to 80 mg once daily, administered in conjunction with other lipid-lowering therapies (e.g., LDL apheresis) or if such therapies are not possible.
The recommended starting dose for pediatric patients (10 to 17 years old) with heterozygous familial hypercholesterolemia is 10 mg once daily, with a maximum dose of 20 mg once daily. The dosage should be adjusted according to treatment goals and be administered with at least 4-week intervals.
This medication may cause muscle abnormalities, so patients should consult a doctor immediately if they experience muscle pain or weakness symptoms. For patients at a high risk of muscle damage, it may be necessary to temporarily suspend or discontinue this medication. Patients with poor liver function or a history of liver disease must consult a doctor before using this medication. Women who are pregnant or may become pregnant should not take this medication, and effective contraception should be used during treatment. It is also safe for breastfeeding women to avoid using this medication. Children, especially those under 10 years old, should not use this medication. Elderly patients or those with impaired kidney function should use it cautiously due to a higher risk of muscle abnormalities. This medication may interact with certain drugs, so patients taking other medications must inform their doctor or pharmacist. In case of overdose, there is no specific antidote, and appropriate treatment should be administered according to symptoms. Liver function and muscle condition should be regularly monitored. Store this medication out of reach of children and keep it in its original container for safety. If symptoms of hepatitis, skin rash, or allergic reactions such as hives occur during treatment, stop taking the medication immediately and inform medical staff. This medication can elevate blood sugar levels, so patients at risk of diabetes must carefully manage their blood glucose levels. If symptoms such as muscle pain, weakness, fatigue, fever, etc., appear, consult a doctor immediately and undergo tests.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, high fever with severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, respiratory problems, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-sealed container to prevent air or moisture ingress. It is important to maintain storage temperature between 1 to 30 degrees Celsius. This will help preserve the medication's effectiveness and safety for a longer duration.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.